Failed treatment of congenital pseudoarthrosis of the tibia—a case of llizarov-transportation of proximal tibia with arthrodesis to talus

Velan, Gad J.; Katz, Kalman; Hendel, David

doi:10.3109/17453679808999062

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another disadvantage of the Ilizarov method is the external device, which is not well tolerated by pediatric patients. The multiple complications with this procedure include dorsiflexion contracture of the ankle with calcaneo-valgus deformity, joint stiffness, cystic bone lesions, nail infections, cartilage necrosis, injury to a nerve and possible appearance of compartment syndromes (56).…”

Section: Discussionmentioning

confidence: 99%

Orthopaedic manifestations of neurofibromatosis type 1: A case report

et al. 2021

View full text Add to dashboard Cite

Neurofibromatosis type 1 (NF1) or von Recklinghausen disease is one of the most common autosomal dominant genetic diseases. It is characterized by 'café-au-lait' spots and multiple tumors starting from the central and peripheric nervous system. The diagnosis is determined on two out of seven criteria: i) A total of 6 or more light brown spots larger than 5 mm in diameter (pre-puberty) or 15 mm in diameter (post-puberty); ii) a total of 2 or more neurofibromas or one plexiform neurofibroma; iii) axillary or inguinal freckling; iv) optic glioma; v) a total of 2 or more Lisch nodules; vi) bone abnormalities: tibia pseudarthrosis or dysplasia of the sphenoid wing; and vii) a relative of first degree having an NF1 diagnosis. A total of ~50% of patients have significant musculoskeletal manifestation, with scoliosis and congenital pseudarthrosis of tibia most common. Management of the orthopaedic manifestations of NF1 is often difficult. Due to NF1 influencing multiple organ systems, patients are likely to benefit most from a multidisciplinary treatment strategy.

show abstract

Section: Discussionmentioning

confidence: 99%